A Study to Assess the Effect of Pacibekitug on Major Cardiovascular Events in Patients After a Myocardial Infarction
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 10000 participants.
Also called NCT07938411
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 10,000 participants
- Sponsor
- Registry
-
NCT07938411 -
2026-525816-33
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07938411. Randomized; double masking; primary purpose treatment. Start 2026-11-30 (anticipated); primary completion 2030-10-22 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Assess the Effect of Pacibekitug on Major Cardiovascular Events in Patients After a Myocardial Infarction
- Acronym
- PINNACLE-MI
- Condition
- Myocardial Infarction
- Intervention (Drug)
- Pacibekitug
- Intervention (Drug)
- Placebo
- Lead sponsor
- Novartis Pharmaceuticals
Record details
- Record id
cardio:ct-nct07938411- Content hash
e36962d797a694a6d48c82d3391243169fa999f549055d1acd5086e69a442c14